Posted by kinasepro on July 30, 2009
WO/2009/093972 reminds you of…
This entry was posted on July 30, 2009 at 8:20 am and is filed under Astra, pi3k.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
AstarZeneca has had PIK3beta for some time. AZD-6482 commenced phase I studies, for thrombosis, in January 2008. It’s still in phase I according to the 30 July 2009 update.
Does anybody know of any publications with this compound? Is it commercially available from any small companies?
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.